Viz.ai Implementation of Stroke Augmented Intelligence and Communications Platform to Improve Indicators and Outcomes for a Comprehensive Stroke Center and Network

References

1. 1.↵
   The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87 doi:10.1056/NEJM199512143332401 pmid:7477192

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Fransen PS,
   2. Beumer D,
   3. Berkhemer OA, et al

   ; MR CLEAN Investigators. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials 2014;15:343 doi:10.1186/1745-6215-15-343 pmid:25179366

   CrossRefPubMed
3. 3.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   ; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
4. 4.↵
   1. Albers GW,
   2. Marks MP,
   3. Kemp S, et al

   ; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–18 doi:10.1056/NEJMoa1713973 pmid:29364767

   CrossRefPubMed
5. 5.↵
   1. Nogueira RG,
   2. Jadhav AP,
   3. Haussen DC, et al

   ; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
6. 6.↵
   1. Saver JL,
   2. Goyal M,
   3. van der Lugt A, et al

   ; HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279–88 doi:10.1001/jama.2016.13647 pmid:27673305

   CrossRefPubMed
7. 7.↵
   Target: Stroke Phase III. Introducing Target: Stroke Phase III. https://www.heart.org/en/professional/quality-improvement/target-stroke/introducing-target-stroke-phase-iii. Accessed October 6, 2022
8. 8.↵
   1. Grotta JC

   . tPA for stroke: important progress in achieving faster treatment. JAMA 2014;311:1615–17 doi:10.1001/jama.2014.3322 pmid:24756509

   CrossRefPubMed
9. 9.↵
   1. Fonarow GC,
   2. Zhao X,
   3. Smith EE, et al

   . Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014;311:1632–40 doi:10.1001/jama.2014.3203 pmid:24756513

   CrossRefPubMed
10. 10.↵
    1. Lopez-Rivera V,
    2. Salazar-Marioni S,
    3. Abdelkhaleq R, et al

    . Integrated stroke system model expands availability of endovascular therapy while maintaining quality outcomes. Stroke 2021;52:1022–29 doi:10.1161/STROKEAHA.120.032710 pmid:33535778

    CrossRefPubMed
11. 11.↵
    1. Goyal M,
    2. Menon BK,
    3. van Zwam WH, et al

    ; HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

    CrossRefPubMed
12. 12.↵
    1. Kim SC,
    2. Lee CY,
    3. Kim CH, et al

    . The effectiveness of systemic and endovascular intra-arterial thrombectomy protocol for decreasing door-to-recanalization time duration. J Cerebrovasc Endovasc Neurosurg 2022;24:24–35 doi:10.7461/jcen.2021.E2021.07.009 pmid:34696551

    CrossRefPubMed
13. 13.↵
    1. Aghaebrahim A,
    2. Streib C,
    3. Rangaraju S, et al

    . Streamlining door to recanalization processes in endovascular stroke therapy. J Neurointerv Surg 2017;9:340–45 doi:10.1136/neurintsurg-2016-012324 pmid:27048957

    Abstract/FREE Full Text
14. 14.↵
    1. Frei D,
    2. McGraw C,
    3. McCarthy K, et al

    . A standardized neurointerventional thrombectomy protocol leads to faster recanalization times. J Neurointerv Surg 2017;9:1035–40 doi:10.1136/neurintsurg-2016-012716 pmid:27811176

    Abstract/FREE Full Text
15. 15.↵
    1. Panezai S,
    2. Meghpara S,
    3. Kulhari A, et al

    . Institution of Code Neurointervention and its impact on reaction and treatment times. J Vasc Interv Neurol 2020;11:1–5

    PubMed
16. 16.↵
    1. Jahan R,
    2. Saver JL,
    3. Schwamm LH, et al

    . Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice. JAMA 2019;322:252–63 doi:10.1001/jama.2019.8286 pmid:31310296

    CrossRefPubMed
17. 17.↵
    1. Modir R,
    2. Meyer D,
    3. Hamidy M, et al

    . Brain emergency management initiative for optimizing Hub-Helicopter Emergency Medical Systems-Spoke Transfer Networks. Air Med J 2020;39:103–06 doi:10.1016/j.amj.2019.10.003 pmid:32197685

    CrossRefPubMed
18. 18.↵
    1. Mendez B,
    2. Requena M,
    3. Aires A, et al

    . Direct transfer to angio-suite to reduce workflow times and increase favorable clinical outcome. Stroke 2018;49:2723–27 doi:10.1161/STROKEAHA.118.021989 pmid:30355182

    CrossRefPubMed
19. 19.↵
    1. Meyer BC,
    2. Raman R,
    3. Hemmen T, et al

    . Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008;7:787–95 doi:10.1016/S1474-4422(08)70171-6 pmid:18676180

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Goyal M,
    2. Jadhav AP,
    3. Bonafe A, et al

    ; SWIFT PRIME Investigators. Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the SWIFT PRIME randomized controlled trial. Radiology 2016;279:888–97 doi:10.1148/radiol.2016160204 pmid:27092472

    CrossRefPubMed
21. 21.↵
    1. Gache K,
    2. Leleu H,
    3. Nitenberg G, et al

    . Main barriers to effective implementation of stroke care pathways in France: a qualitative study. BMC Health Serv Res 2014;14:95 doi:10.1186/1472-6963-14-95 pmid:24575955

    CrossRefPubMed
22. 22.↵
    1. Kidwell CS,
    2. Jahan R,
    3. Gornbein J, et al

    ; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914–23 doi:10.1056/NEJMoa1212793 pmid:23394476

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Murray NM,
    2. Unberath M,
    3. Hager GD, et al

    . Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review. J Neurointerv Surg 2020;12:156–64 doi:10.1136/neurintsurg-2019-015135 pmid:31594798

    Abstract/FREE Full Text
24. 24.↵
    1. Mehta BP,
    2. Leslie-Mazwi TM,
    3. Chandra RV, et al

    . Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc 2014;3:e000963 doi:10.1161/JAHA.114.000963 pmid:25389281

    Abstract/FREE Full Text
25. 25.↵
    1. Lin CB,
    2. Peterson ED,
    3. Smith EE, et al

    . Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2012;5:514–22 doi:10.1161/CIRCOUTCOMES.112.965210 pmid:22787065

    Abstract/FREE Full Text
26. 26.↵
    1. Patel MD,
    2. Rose KM,
    3. O’Brien EC, et al

    . Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. Stroke 2011;42:2263–68 doi:10.1161/STROKEAHA.110.605857 pmid:21659638

    Abstract/FREE Full Text
27. 27.↵
    1. Al-Kawaz M,
    2. Primiani C,
    3. Urrutia V, et al

    . Impact of RapidAI mobile application on treatment times in patients with large vessel occlusion. J Neurointerv Surg 2022;14:233–36 doi:10.1136/neurintsurg-2021-017365 pmid:33795483

    Abstract/FREE Full Text